Venatorx Pharmaceuticals Announces Changes to Executive Leadership

By WebmasterMay 16, 2024December 12th, 2024No Comments

Venatorx Pharmaceuticals Announces Changes to Executive Leadership

Previous PostAccelerated Biosciences and Spanios Partner to Advance Therapeutic Design Across Solid Tumor Cancers
Next PostCoherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer